Accurate Detection of Tumor-Specific Gene Fusions Reveals Strongly Immunogenic Personal Neo-Antigens

By testing immunogenicity with autologous blood lymphocytes from patients with cancer, scientists detected pre-established CD4+ and CD8+ T cell responses for 10 of 21 and for 1 of 30 previously identified gene fusions, respectively.